Who Manufactures Esomeprazole Injection?
Several pharmaceutical companies supply esomeprazole for injection. These include Fresenius Kabi USA, Fresenius Kabi Pharmaceutical, Fresenius SE & Co. KGaA, and Hikma Pharmaceuticals PLC [1]. HEC Pharm USA, Inc. also distributes esomeprazole injection [1].
What Are the Common Brands of Esomeprazole Injection?
Esomeprazole injection is available under various brand names. Nexium is a widely recognized brand [2]. Manufacturers also produce generic versions of esomeprazole for injection [1].
What Is Esomeprazole Injection Used For?
Esomeprazole injection is a proton pump inhibitor (PPI) used to treat gastroesophageal reflux disease (GERD) and to heal erosive esophagitis [2]. It is also prescribed for the treatment of conditions that produce too much stomach acid, such as Zollinger-Ellison syndrome [2]. It can be used intravenously when oral administration is not feasible [2].
How Does Esomeprazole Injection Work?
Esomeprazole works by reducing the amount of acid produced in the stomach [2]. It is the S-isomer of omeprazole and inhibits the gastric parietal cell proton pump [3].
What Is the Patent Status of Esomeprazole?
Drug patents, including those for esomeprazole, are critical for market exclusivity. Information on specific patents and their expiration dates can be found through resources like DrugPatentWatch.com [4]. Patent expiry is a key factor in the introduction of generic alternatives.
Who Are the Competitors for Esomeprazole Injection?
The market for acid-reducing medications is competitive, with other proton pump inhibitors (PPIs) and H2 blockers available. Other PPIs include omeprazole, lansoprazole, pantoprazole, and rabeprazole. H2 blockers like ranitidine and famotidine also compete in this therapeutic area [3]. The development of generic esomeprazole injection has increased competition.
What Are the Risks Associated with Esomeprazole Injection?
Potential risks associated with esomeprazole injection include common side effects like headache, diarrhea, nausea, and stomach pain [2]. Long-term use of PPIs, including esomeprazole, has been associated with an increased risk of bone fractures, C. difficile infection, and low magnesium levels [2]. It is important to discuss these risks with a healthcare provider.